CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

EAGLE PHARMACEUTICALS, INC.

EGRX
$3MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for EGRX. That does not mean none is planned.

Get an email about EGRX's next catalysts

Track EAGLE PHARMACEUTICALS (EGRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWOODCLIFF LAKE134 employees
Drug Pipeline

Frequently asked questions

What is in EAGLE PHARMACEUTICALS, INC.'s drug pipeline?β†’

CatalystAlert tracks 5 drug candidates in EAGLE PHARMACEUTICALS, INC.'s (EGRX) pipeline across Phase 3, Phase 2. Its lead program is Mesalamine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is EAGLE PHARMACEUTICALS, INC.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for EAGLE PHARMACEUTICALS, INC. (EGRX) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track EGRX biotech catalysts?β†’

Add EGRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow EAGLE PHARMACEUTICALS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply